Low-molecular-weight heparin (LMWH) in women with repeated implantation failure

Journal of Obstetrics and Gynecology of India

Volumn 62, Issue 4, 2012, Pages 381-383

  Allahbadia, Gautam N ^a  

^a Near Otters Club   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 5; CARDIOLIPIN; CHORIONIC GONADOTROPIN; DALTEPARIN; ENOXAPARIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GONADOTROPIN; HEPARAN SULFATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCORTIN 5; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PROTHROMBIN; SOMATOMEDIN; UVOMORULIN;

ABORTION; ANTICOAGULATION; BIRTH RATE; CELL DIFFERENTIATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; LUTEAL PHASE; NIDATION; OOCYTE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; PREGNANCY DISORDER; PREGNANCY RATE; PREGNANCY TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOPHILIA; THROMBOSIS; TROPHOBLAST;

EID: 84872344322     PISSN: 09719202     EISSN: 09756434     Source Type: Journal    
DOI: 10.1007/s13224-012-0308-8     Document Type: Review

References (15)

1. Allahbadia GN, Kadam K, Gandhi G, et al. Embryo transfer using the SureView catheter-beacon in the womb. Fertil Steril. 2010;93(2):344-50.
2. Fiedler K, Wurfel W. Effectivity of heparin in assisted reproduction. Eur J Med Res. 2004;9:207-14.
3. Empson M, Lassere M, Craig J, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005;2:CD002859.
4. Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med. 2004;10:1222-6.
5. Qublan H, Amarin Z, Dabbas M, et al. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb). 2008;11(4):246-53.
6. Noci I, MilaniniMN, RuggieroM, et al. Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: a pilot study. Reprod Biomed Online. 2011;22(6):615-20.
7. Urman B, Ata B, Yakin K, et al. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum Reprod. 2009;24(7):1640-7.
8. Jerzak M, Niemiec T, Nowakowska A, et al. First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles - case report. Am J Reprod Immunol. 2010;64(2):93-6.
9. Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update. 2008;14(6):623-45.
10. Xue WC, Feng HC, Tsao SW, et al. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Int J Gynecol Cancer. 2003;13:879-88.
11. Hamatani T, Daikoku T, Wang H, et al. Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. Proc Natl Acad Sci USA. 2004;101:10326-31.
12. Leach RE, Kilburn B, Wang J, et al. Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype. Dev Biol. 2004;266:223-37.
13. Halbmayer WM, Feichtinger W, Kindermann C, et al. Recurrent miscarriage or failed in vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance. Hamostaseologie. 2005;25(4):391-3.
14. Lodigiani C, Di Micco P, Ferrazzi P, et al. Low-molecular-weight heparin in women with repeated implantation failure. Womens Health (Lond Engl). 2011;7(4):425-31.
15. Bohlmann MK. Effects and effectiveness of heparin in assisted reproduction. J Reprod Immunol. 2011;90(1):82-90.